Abstract

It is shown that the level of total serum cholesterol dropped and the rate of cholesterol synthesis in lymphocytes remained unchanged after 12 months of lovastatin treatment (20 mg/day) in patients with coronary heart disease. The administration of lovastatin abolished the deleterious effect of obsidan on the blood lipid spectrum.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call